Comparison of diagnostic sensitivity of [18F]fluoroestradiol and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer.
Sun Young ChaeHye Joo SonDong Yun LeeEonwoo ShinJungsu S OhSeung Yeon SeoSora BaekJi Young KimSae Jung NaDae Hyuk MoonPublished in: EJNMMI research (2020)
The restaging of patients who had ER-positive primary breast cancer and present with recurrent disease may include [18F]FES PET/CT as an initial test when standard imaging studies are equivocal or suspicious.